Department of Molecular Medicine & Biotechnology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Department of Urology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
J Cell Biochem. 2022 Aug;123(8):1327-1339. doi: 10.1002/jcb.30294. Epub 2022 May 29.
Gluconeogenesis is one of the key processes through which the kidney contributes to glucose homeostasis. Urinary exosomes (uE) have been used to study renal gene regulation noninvasively in humans and rodents. Recently, we demonstrated fast-fed regulation of phosphoenolpyruvate carboxykinase (PEPCK), the rate-limiting enzyme for gluconeogenesis, in human uE. The regulation was impaired in subjects with early insulin resistance. Here, we studied primary human proximal tubule cells (hPT) and human uE to elucidate a potential link between insulin resistance and fast-fed regulation of renal PEPCK. We demonstrate that fasted hPTs had higher PEPCK and insulin receptor substrate-2 (IRS2) mRNA and protein levels, relative to fed cells. The fast-fed regulation was, however, attenuated in insulin receptor knockdown (IRKO) hPTs. The IRKO was confirmed by the blunted insulin-induced response on PEPCK, PGC1α, p-IR, and p-AKT expression in IRKO cells. Exosomes secreted by the wild-type or IRKO hPT showed similar regulation to the respective hPT. Similarly, in human uE, the relative abundance of IRS-2 mRNA (to IRS1) was higher in the fasted state relative to the fed condition. However, the fast-fed difference was absent in subjects with early insulin resistance. These subjects had higher circulating glucagon levels relative to subjects with optimal insulin sensitivity. Furthermore, in hPT cells, glucagon significantly induced PEPCK and IRS2 gene, and gluconeogenesis. IR knockdown in hPT cells further increased the gene expression levels. Together the data suggest that reduced insulin sensitivity and high glucagon in early insulin resistance may impair renal gluconeogenesis via IRS2 regulation.
糖异生是肾脏参与血糖稳态的关键过程之一。尿外泌体 (uE) 已被用于在人类和啮齿动物中研究肾脏基因调节的非侵入性方法。最近,我们证明了人 uE 中磷酸烯醇丙酮酸羧激酶 (PEPCK) 的快速进食调节,PEPCK 是糖异生的限速酶。这种调节在早期胰岛素抵抗的受试者中受损。在这里,我们研究了原代人近端肾小管细胞 (hPT) 和人 uE,以阐明胰岛素抵抗与肾脏 PEPCK 的快速进食调节之间的潜在联系。我们证明,与进食细胞相比,禁食 hPTs 具有更高的 PEPCK 和胰岛素受体底物-2 (IRS2) mRNA 和蛋白水平。然而,在胰岛素受体敲低 (IRKO) hPTs 中,快速进食调节减弱。IRKO 通过 IRKO 细胞中 PEPCK、PGC1α、p-IR 和 p-AKT 表达的胰岛素诱导反应减弱得到证实。野生型或 IRKO hPT 分泌的外泌体表现出与各自 hPT 相似的调节作用。同样,在人 uE 中,IRS-2 mRNA(相对于 IRS1)的相对丰度在禁食状态下高于进食状态。然而,在早期胰岛素抵抗的受试者中,这种快速进食差异不存在。这些受试者的循环胰高血糖素水平相对具有最佳胰岛素敏感性的受试者更高。此外,在 hPT 细胞中,胰高血糖素显著诱导 PEPCK 和 IRS2 基因以及糖异生。IR 在 hPT 细胞中的敲低进一步增加了基因表达水平。总之,这些数据表明,早期胰岛素抵抗中胰岛素敏感性降低和胰高血糖素升高可能通过 IRS2 调节损害肾脏糖异生。